• Mashup Score: 0
    Evolution of the Pulse Ox - 10 month(s) ago

    Section snippetsFunding/SupportThe authors were funded by the Intramural Research Program, National Institutes of Health/National Heart, Lung, and Blood Institute.Financial/Nonfinancial DisclosuresNone declared.AcknowledgmentsOther contributions: We thank Dr Robert S. Balaban for helpful discussions on the mechanisms of pulse oximeter discrepancies based on skin color.Role of sponsors: The…

    Tweet Tweets with this article
    • .@NIH_NHLBI: New Funding Opportunity. Read the commentary in #CHEST by Bennett Yang & Joel Moss on the evolution of the pulse oximeter and the related new Small Business Innovation Research funding opportunity. #NHLBI #SBIR #NOFO #Technology #COVID #Oxygen https://t.co/e4EMC2Ybrx https://t.co/6J34p4Xy3A

  • Mashup Score: 0

    Remote monitoring of patients with COVID-19 and exertional hypoxia treated with supplemental oxygen at home was linked to a lower number of days in the hospital, according to a research letter published in CHEST.However, these patients, especially those aged 70 years or older, had higher odds for ICU admission or death, according to researchers.

    Tweet Tweets with this article
    • Patients with #COVID19 being monitored remotely with home #oxygen had fewer days in the hospital, but older patients had longer #ICU stays and higher odds for ICU admission or death. https://t.co/cIkKZKZyp2

  • Mashup Score: 0

    Remote monitoring of patients with COVID-19 and exertional hypoxia treated with supplemental oxygen at home was linked to a lower number of days in the hospital, according to a research letter published in CHEST.However, these patients, especially those aged 70 years or older, had higher odds for ICU admission or death, according to researchers.

    Tweet Tweets with this article
    • According to a research letter published in @journal_CHEST, remote monitoring of patients with #COVID19 and exertional #hypoxia treated with supplemental #oxygen at home was linked to a lower number of days in the hospital. https://t.co/cIkKZKZyp2

  • Mashup Score: 0

    The FDA has granted 510(k) clearance to a prescription pulse oximeter in the form of a sock for monitoring oxygen saturation levels of infants, according to a manufacturer-issued press release.According to the release, the BabySat monitoring system (Owlet) allows physicians and parents/guardians to oversee a baby’s real-time oxygen saturation levels and heart rate at home. With tracking of

    Tweet Tweets with this article
    • According to a press release from Owlet, the BabySat monitoring system allows physicians and parents/guardians to oversee a baby’s real-time #oxygen saturation levels and heart rate at home. https://t.co/zPLbHwb35p

  • Mashup Score: 0

    The FDA has granted 510(k) clearance to a prescription pulse oximeter in the form of a sock for monitoring oxygen saturation levels of infants, according to a manufacturer-issued press release.According to the release, the BabySat monitoring system (Owlet) allows physicians and parents/guardians to oversee a baby’s real-time oxygen saturation levels and heart rate at home. With tracking of

    Tweet Tweets with this article
    • The @US_FDA has granted 510(k) #clearance to a prescription pulse #oximeter in the form of a sock for monitoring #oxygen saturation levels of infants, according to a manufacturer-issued press release. @IDinChildren https://t.co/zPLbHwb35p

  • Mashup Score: 0

    Higher dose corticosteroids heightened the risk for mortality in patients hospitalized with COVID-19 who need oxygen therapy compared with usual care/low dose corticosteroids, according to study results published in The Lancet.These results were also presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases.

    Tweet Tweets with this article
    • ICYMI: Higher dose #corticosteroids heightened the risk for mortality in patients hospitalized with #COVID-19 who need #oxygen therapy compared with usual care/low dose corticosteroids, according to study results published in @TheLancet. https://t.co/JDYsnS21sj

  • Mashup Score: 0

    Healio has compiled the most-read news in pulmonology posted in April.Highlights include a study showing that nonprescription portable oxygen concentrators may not be helpful for those who need ambulatory oxygen; the FDA’s class I recall of Philips Respironics DreamStation devices; the FDA’s approval of cystic fibrosis triple therapy for children aged 2 to 5 years; several FDA

    Tweet Tweets with this article
    • Healio Pulmonology's most-read news story from April was on a study showing that nonprescription portable oxygen concentrators may not be helpful for those who need ambulatory #oxygen. Click the link below to read this and more top stories from April. https://t.co/HvxvUcVFDv